Presentation TVT 2014 Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study Presenter: Susheel Kodali June 06, 2014 REGISTER for free or LOG IN to view this content Coronary Aortic Valve Presentation TVT 2014 Up Next Presentation TVT 2014 Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials) Presenter: Alexandra J. Lansky June 06, 2014 More slides + Presentation TVT 2014 Indications, Technique, and Results of Postdilation After CoreValve Presenter: Nicolas M. van Mieghem June 07, 2014 Presentation TVT 2014 A Critical Analysis of Present Data on Cerebral Protection after TAVR Presenter: Axel Linke June 07, 2014 We Recommend
Presentation TVT 2014 Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials) Presenter: Alexandra J. Lansky June 06, 2014
Presentation TVT 2014 Indications, Technique, and Results of Postdilation After CoreValve Presenter: Nicolas M. van Mieghem June 07, 2014
Presentation TVT 2014 A Critical Analysis of Present Data on Cerebral Protection after TAVR Presenter: Axel Linke June 07, 2014